tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ALNY Stock Latest News

Alnylam price target raised to $385 from $384 at Canaccord
The FlyAlnylam price target raised to $385 from $384 at Canaccord
2d ago
ALNY
Alnylam Pharma: Hold Rating Due to Stable Financials and Uncertain Pipeline Prospects
PremiumRatings
Alnylam Pharma: Hold Rating Due to Stable Financials and Uncertain Pipeline Prospects
3d ago
ALNY
Alnylam Pharmaceuticals’ Earnings Call Highlights Strong Growth
PremiumCompany Announcements
Alnylam Pharmaceuticals’ Earnings Call Highlights Strong Growth
4d ago
ALNY
Alnylam price target lowered to $300 from $310 at Scotiabank
PremiumThe Fly
Alnylam price target lowered to $300 from $310 at Scotiabank
6d ago
ALNY
Strong Buy Recommendation for Alnylam Pharma Amid Upcoming PDUFA Date and Promising Growth Prospects
PremiumRatings
Strong Buy Recommendation for Alnylam Pharma Amid Upcoming PDUFA Date and Promising Growth Prospects
6d ago
ALNY
Alnylam Pharmaceuticals Reports Strong 2024 Growth
PremiumCompany AnnouncementsAlnylam Pharmaceuticals Reports Strong 2024 Growth
7d ago
ALNY
Alnylam Pharma Receives Buy Rating: Strong Revenue Growth, Regulatory Approvals, and International Expansion Fuel Positive Outlook
Premium
Ratings
Alnylam Pharma Receives Buy Rating: Strong Revenue Growth, Regulatory Approvals, and International Expansion Fuel Positive Outlook
7d ago
ALNY
Alnylam Pharma’s Promising Outlook: Buy Rating Backed by Strong Sales, Strategic Developments, and Profitability Potential
Premium
Ratings
Alnylam Pharma’s Promising Outlook: Buy Rating Backed by Strong Sales, Strategic Developments, and Profitability Potential
7d ago
ALNY
Alnylam sees FY25 revenue $2.05B-$2.25B, consensus $2.68B
PremiumThe Fly
Alnylam sees FY25 revenue $2.05B-$2.25B, consensus $2.68B
7d ago
ALNY
Alnylam reports Q4 EPS (6c), consensus (14c)
PremiumThe Fly
Alnylam reports Q4 EPS (6c), consensus (14c)
7d ago
ALNY
Alnylam Pharmaceuticals (ALNY) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Alnylam Pharmaceuticals (ALNY) Q4 Earnings Cheat Sheet
9d ago
ALNY
Alnylam treatment of ATTR amyloidosis granted orphan designation
PremiumThe Fly
Alnylam treatment of ATTR amyloidosis granted orphan designation
16d ago
ALNY
Alnylam added to US Conviction List at Goldman Sachs
PremiumThe FlyAlnylam added to US Conviction List at Goldman Sachs
17d ago
ALNY
Alnylam positive reaction to guidance ‘makes sense,’ says JPMorgan
Premium
The Fly
Alnylam positive reaction to guidance ‘makes sense,’ says JPMorgan
1M ago
ALNY
Alnylam reports preliminary FY24 product revenues $1.646B, up 33% versus FY23
Premium
The Fly
Alnylam reports preliminary FY24 product revenues $1.646B, up 33% versus FY23
1M ago
ALNY
Alnylam price target lowered to $310 from $314 at Bernstein
PremiumThe Fly
Alnylam price target lowered to $310 from $314 at Bernstein
1M ago
ALNY
TransMedics names Gerardo Hernandez as CFO, succeeding Stephen Gordon
PremiumThe Fly
TransMedics names Gerardo Hernandez as CFO, succeeding Stephen Gordon
3M ago
ALNY
TMDX
FDA accepts Alnylam’s sNDA for vutrisiran for ATTR-CM treatment
PremiumThe Fly
FDA accepts Alnylam’s sNDA for vutrisiran for ATTR-CM treatment
3M ago
ALNY
Alnylam Pharmaceuticals announces interim Phase 1 data of nucresiran
PremiumThe Fly
Alnylam Pharmaceuticals announces interim Phase 1 data of nucresiran
3M ago
ALNY
BridgeBio price target raised to $45 from $44 at Scotiabank
PremiumThe FlyBridgeBio price target raised to $45 from $44 at Scotiabank
3M ago
ALNY
BBIO
Alnylam cut to Underperform at Wolfe Research amid Amvuttra expansion
Premium
The Fly
Alnylam cut to Underperform at Wolfe Research amid Amvuttra expansion
3M ago
ALNY
Alnylam downgraded to Underperform from Peer Perform at Wolfe Research
Premium
The Fly
Alnylam downgraded to Underperform from Peer Perform at Wolfe Research
3M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >